BioInformatics releases more results from COVID-19 lab tracker survey
April 16, 2020 -- Scientists whose labs have been closed due to the COVID-19 pandemic are spending their time writing and planning future research projects, according to new details released from a survey of lab closures by market research firm BioInformatics. Read More
Scripps Research expands drug repurposing efforts for COVID-19
April 16, 2020 -- Scripps Research has pivoted its drug repurposing collection ReFRAME to find antiviral compounds effective against the novel coronavirus. Read More
COVID-19 research consortium expands
April 15, 2020 -- The EndPandemic National Data Consortium is about to expand by six life sciences and information technology companies. Read More
Chicago's McCormick Place to house COVID-19 patients
April 15, 2020 -- The McCormick Place convention center in Chicago is being converted into an alternate care facility that can house up to 3,000 patients with COVID-19. Read More
NIH tests for SARS-CoV-2 antibodies in the general population
April 15, 2020 -- The U.S. National Institutes of Health (NIH) has commenced a study to determine how many adults in the U.S. with no confirmed history of infection with SARS-CoV-2 have antibodies to the virus. Read More
New COVID-19 R&D initiatives announced
April 15, 2020 -- A series of new initiatives aims to simplify scientific literature discovery and acquisition during the COVID-19 crisis, according to Research Solutions. These products include the launch of the COVID-19 Research Viewer Gadget. Read More
ThermoGenesis to develop COVID-19 therapeutics
April 13, 2020 -- ThermoGenesis has announced that its joint venture, ImmuneCyte Life Sciences, has acquired intellectual property for developing antibody therapeutics for COVID-19. Read More
Eurofins Discovery supports COVID-19 research
April 13, 2020 -- Eurofins Discovery has announced that it aims to accelerate COVID-19 antiviral drug discovery research. Read More
Samsung Biologics, Vir partner on SARS-CoV-2 program
April 10, 2020 -- Samsung Biologics announced it will manufacture Vir Biotechnology's SARS-CoV-2 monoclonal antibody program for a potential COVID-19 treatment. Read More
Enzychem files patent application for COVID-19 drug candidate
April 10, 2020 -- Enzychem Lifesciences has filed a provisional patent application with the U.S. Patent and Trademark Office to cover treating COVID-19 with its compound EC-18. Read More
Conferences
BioTech Pharma Summit
September 27-28
Porto Portugal
Infectious Diseases (ID) Week 2021
September 29 - October 3
San Diego, California United States
Imaging Mass Spectrometry Society (IMSS) 3 in 2021
October 3-6
Colorado Springs, Colorado United States
Cell & Gene Meeting on the Mesa
October 10-14
Carlsbad, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter